GLP-1 Introduction

GLP‑1 agonists are a class of medications that mimic the body’s natural gut hormones, effectively supporting weight loss and stabilizing blood glucose. Their actions include:

  • Regulating the brain’s appetite center to reduce hunger
  • Stimulating insulin secretion to help stabilize blood sugar
  • Delaying gastric emptying to prolong feelings of fullness

Currently marketed patented GLP‑1 weight‑loss drugs include:

  • Mounjaro (Tirzepatide injection)
  • Rybelsus (Semaglutide oral tablets)
  • Wegovy (Semaglutide inj., weight-loss)
  • Ozempic (Semaglutide inj., diabetes)

We offer generic GLP‑1 versions with the same proven efficacy at more affordable prices, so you can pursue better health without the burden of high drug costs.

Choose us, and let more accessible treatment options be the first step toward a better life.

猛健樂（Mounjaro）

Tirzepatide Injection

Innovator’s Brand Name: Mounjaro

Generic Brand Name: Tizaro

Dosage Frequency: Once weekly

Overview: Currently the most effective GLP‑1 product for weight loss. Clinical trial data show that overweight or obese patients treated with tirzepatide for 72 weeks achieved an average weight reduction of 22.5%.

Click to buy

Semaglutide Oral

Innovator’s Brand Name: Rybelsus

Generic Brand Name: Semaglo

Dosage Frequency: Once daily

Overview: The oral formulation of semaglutide. Offers the advantages of room‑temperature storage and no injections required; however, its weight‑loss efficacy is lower than that of the injectable version.

Click to buy

Semaglutide Injection (Weight-Loss)

Innovator’s Brand Name: Wegovy

Generic Brand Name: Semaglo OB

Dosage Frequency: Once weekly

Overview: The world’s first weekly GLP‑1 injectable. Clinical studies show that overweight or obese patients treated with semaglutide for 72 weeks achieved an average weight reduction of 20.7%.

Click to buy

Semaglutide Injection (Diabetes)

Innovator’s Brand Name: Ozempic

Generic Brand Name: Semaglo Inj

Dosage Frequency: Once weekly

Indicated for patients with type 2 diabetes. Contains the same active ingredient as the weight‑loss formulation; however, the glycemic‑control version’s maximum dose is 0.5 mg, compared to 2.4 mg for the weight‑loss version.

Click to buy

GLP-1 Latest News

1 3